gadolinium has been researched along with Burkitt Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boukriche, Y; Felce-Dachez, M; Guilmin, F; Krainik, A; Masson, C; Rosenberg, C | 1 |
| Hattner, RS; White, DL | 1 |
2 other study(ies) available for gadolinium and Burkitt Lymphoma
| Article | Year |
|---|---|
[MRI of a cauda equina lymphoma].
Topics: Burkitt Lymphoma; Cauda Equina; Contrast Media; Fatal Outcome; Gadolinium; Humans; Lymphoma, AIDS-Related; Magnetic Resonance Imaging; Male; Middle Aged; Peripheral Nervous System Neoplasms; Polyradiculopathy; Shock, Septic | 2002 |
Gallium-67/stable gadolinium antagonism: MRI contrast agent markedly alters the normal biodistribution of gallium-67.
Topics: Burkitt Lymphoma; Child; Drug Interactions; Gadolinium; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Radionuclide Imaging; Tissue Distribution; Whole-Body Counting | 1990 |